In March 2010, Polygen Pharmaceuticals LLC (“POLYGEN”) was founded to develop, manufacture, package & distribute high-quality generic pharmaceuticals (OTC Monograph & ANDA drug Products) and nutraceuticals.
The company is dedicated to bringing new, high-quality generic products to the world market with therapeutic equivalence compared to brand-name products. From the very beginning, Polygen has been exposed to Good Manufacturing Practices, systems and work culture of the best pharmaceutical companies of the world. Equipped with highly committed and skilled man power, modern manufacturing facilities and continuous R & D activities, Polygen is having vision to achieve its motto to provide quality healthcare services to the community at large.
Polygen is engaged in manufacturing & distributing a range of the products in accordance with cGMP regulations as per 21 CFR parts 210 & 211. Moreover, the firm meets the registration & listing requirements set forth at 21 CFR part 207, as authorized or required under section 510 of the Federal Food, Drug & Cosmetic Act.
Strategic partnerships are an integral component of the company’s growth strategy.
Strong distribution relationships with top US retail chains, wholesalers & distributors.
We offer high-quality, high complementary US-based drug product development & contract manufacturing services. Our company has a remarkable drug product development, regulatory filing expertise & understanding of US generic market requirements.
We use variety of deal structures, ranging from Fee-for service to profit sharing collaborations.
The firm have the following functional working departments in their facility:
Manufacturing (for development of OTC Monograph & ANDA products)
Packaging
Warehouse (for storage/inventory & distribution purpose)
Quality Control
Quality Assurance /Compliance
Regulatory Affairs
Marketing/Business Development
Cutomer Care & Supply Chain Management
Polygen is being managed by highly qualifie
Products / Services
Generic Pharmaceuticals
Involved in the distribution of the following approved ANDA products (manufactured by approved vendor/s)-
Ibuprofen Soft Gelatin Capsules, 200 mg (OTC)
Ibuprofen Tablets, USP 200 mg (OTC)
Ibuprofen Tablets, USP 400 mg, 600 mg & 800 mg (Rx)
Naproxen Tablets, USP 250 mg, 375 mg & 500 mg (Rx)
Naproxen Sodium Tablets USP 220 mg (OTC)
Will be involved in the distribution of the following OTC Monograph Products:
Acetamenophen35kdkdkdk
Diphenhydramine
Guafenesin
Hydrobromide$12,000,0003535
In March 2010, Polygen Pharmaceuticals LLC (“POLYGEN”) was founded to develop, manufacture, package & distribute high-quality generic pharmaceuticals (OTC Monograph & ANDA drug Products) and nutraceuticals.
The company is dedicated to bringing new, high-quality generic products to the world market with therapeutic equivalence compared to brand-name products. From the very beginning, Polygen has been exposed to Good Manufacturing Practices, systems and work culture of the best pharmaceutical companies of the world.
See Campaign: https://www.equitynet.com/c/polygen-pharmaceuticals-llc?s=p
Contact Information:
Jodi Kraina
Tags:
EquityNet, Equity, Biotech, Drugs, Hospitals, Facilities and Providers, Medical & Healthcare, Pharmaceuticals & Biotech, Industry verticals, Types of Crowdfunding deal
Source: Icrowdnewswire
